Therapy for hepatitis C has been fairly stagnant for the past decade, but the past few years
have seen major progress and evolution, beginning with the approval of two HCV protease …

A stable and persistent Hepatitis C virus (HCV) replication cell culture model was developed
to examine clearance of viral replication during long-term treatment using interferon-α (IFN …

Sarcoidosis is a multisystemic inflammatory disorder with cutaneous lesions present in
about one‐quarter of the patients. Cutaneous lesions have been classified as specific and …

Background: Whether age plays an important role in the outcomes of HCC after RFA
remains controversial. Study: Two hundred fifty-eight consecutive treatment naive HCC …

Background Long‐term outcome of chronic hepatitis C patients with successful viral
eradication seems to be promising. Aim To evaluate mortality, incidence of hepatocellular …

AIM: To assess the clinical, biochemical and virological long-term outcome in chronic
hepatitis C (CHC) patients with a sustained virological response (SVR) after peginterferon …

Chronic, untreated hepatitis C virus (HCV) infection is associated with a poor clinical
prognosis and a detrimental impact on patients' lives, including on work productivity. To …

Aim Recently, elbasvir/grazoprevir combination therapy (EBR/GZR) was reported to have
excellent antiviral effects for chronic genotype 1 hepatitis C virus (HCV) infection. However, it …

El porcentaje de recaída tras el tratamiento de la hepatitis C crónica con interferón alfa (IFN-
a) es elevado y la respuesta sostenida oscila entre el 10 y el 20%. El efecto antiviral …

Hepatitis C virus (HCV) infection is a major public health concern with approximately 3% of
the world's population is infected, posing social, economical and health burden. Less than …